Evidence map›Paper›PMID 32657507›Full record

GuidelinePediatrics international : official journal of the Japan Pediatric Society2020

The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.

Seiichi Kato, Toshiaki Shimizu, Shigeru Toyoda, Benjamin D Gold, Shinobu Ida, Takashi Ishige, Shigeru Fujimura, Shigeru Kamiya, Mutsuko Konno, Kentaro Kuwabara and 4 more

Registry-linked trialAbstract readPractice GuidelineSystematic Review
In one paragraph

Guideline in Pediatrics international : official journal of the Japan Pediatric Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05802732 (Diagnostic Accuracy Of Stool Antigen In Diagnosis Of Helicobacter Pylori Infection In Children), which is not on this map. Cited by 49 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05802732 unknown statusnot on this mapstarted 2023, after this paper: background citation

Diagnostic Accuracy Of Stool Antigen In Diagnosis Of Helicobacter Pylori Infection In Children

TypeobservationalSponsorAssiut UniversityRan2023 to 2024Enrolled63ConditionsHelicobacter Pylori InfectionArmsStool Antigen test
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Prevalence ofWorld journal of gastroenterology · 2024
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.Pediatrics international : official journal of the Japan Pediatric Society · 2020
    Guideline
  8. Trial
  9. Predictors of Resistance in PediatricPathogens (Basel, Switzerland) · 2026
    Article
  10. Observational
  11. Article
  12. Frontiers in pediatrics · 2026
    Article
  13. Review
  14. Global Profile of Drug Resistance Related toHealth science reports · 2025
    Review
  15. Article
  16. Concordance ofMicroorganisms · 2025
    Article
  17. Association ofPediatric gastroenterology, hepatology & nutrition · 2025
    Article
  18. Prevalence, Management, and Outcomes of Non-InvasivePediatric gastroenterology, hepatology & nutrition · 2024
    Article
  19. Article
  20. Accuracy of gastric nodule combined with rapid urease test prediction in diagnosing Helicobacter pylori infection in children.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Seiichi KatoKato Children's Clinic, Natori, Japan.
Toshiaki ShimizuDepartment of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0003-0364-0022
Shigeru ToyodaNojiri Children and Family Clinic, Fujinomiya, Japan.
Benjamin D GoldChildren's Center for Digestive Healthcare, LLC, Atlanta, GA, USA.
Shinobu IdaDepartment of Pediatric Gastroenterology and Endocrinology, Osaka Women's and Children's Hospital, Osaka, Japan.
Takashi IshigeDepartment of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan.ORCID https://orcid.org/0000-0002-2409-7359
Shigeru FujimuraDivision of Clinical Infectious Diseases & Chemotherapy, Tohoku Medical and Pharmaceutical University Graduate School of Pharmaceutical Sciences, Sendai, Japan.
Shigeru KamiyaDepartment of Infectious diseases, Kyorin University School of Medicine, Tokyo, Japan.
Mutsuko KonnoDepartment of Pediatrics, Sapporo Kosei General Hospital, Sapporo, Japan.
Kentaro KuwabaraDepartment of Pediatrics, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
Kosuke UshijimaDepartment of Pediatrics and Child Health, Kurume University School of Medicine, Kurume, Japan.
Norikazu YoshimuraYoshimura Medical Clinic, Osaka, Japan.
Yoshiko NakayamaDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.ORCID https://orcid.org/0000-0003-1992-6834
Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition

Funding

JSPGHAN
6 · The paper itself

Abstract

The Japan Pediatric Helicobacter pylori Study Group published the first guidelines on childhood H. pylori infection in 1997. They were later revised by the Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition (JSPGHAN). The H. pylori eradication rates, when employing triple therapy with amoxicillin and clarithromycin, currently recommended as the first-line therapy of H. pylori infection in Japan, have substantially decreased, creating an important clinical problem worldwide. In Japanese adults, the "test-and-treat" strategy for H. pylori infection is under consideration as an approach for gastric cancer prevention. However, the combined North American and European pediatric guidelines have rejected such a strategy for asymptomatic children. As risk for gastric cancer development is high in Japan, determining whether the "test-and-treat" strategy can be recommended in children has become an urgent matter. Accordingly, the JSPGHAN has produced a second revision of the H. pylori guidelines, which includes discussion about the issues mentioned above. They consist of 19 clinical questions and 34 statements. An H. pylori culture from gastric biopsies is recommended, not only as a diagnostic test for active infection but for antimicrobial susceptibility testing to optimize eradication therapy. Based upon antimicrobial susceptibility testing of H. pylori strains (especially involving clarithromycin), an eradication regimen including use of the antibiotics to which H. pylori is susceptible is recommended as the first-line therapy against H. pylori-associated diseases. The guidelines recommend against a "test-and-treat" strategy for H. pylori infection for asymptomatic children to protect against the development of gastric cancer because there has been no evidence supporting this strategy.

Indexed as

AdolescentAmoxicillinAnti-Bacterial AgentsBiopsyChildChild, PreschoolClarithromycinDelphi TechniqueDrug Resistance, BacterialDrug Therapy, CombinationGastroenterologyHelicobacter InfectionsHelicobacter pyloriHumansInfantJapanAmoxicillinAnti-Bacterial AgentsClarithromycinProton Pump Inhibitorsantibiotic resistancechilderadication therapygastric cancerHelicobacter pylori

Identifiers

PMID32657507
PMCPMC7839701

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.